BioXcel Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BioXcel Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • BioXcel Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 177 %.
  • BioXcel Therapeutics, Inc. annual Return On Equity for 2023 was 1.87K %.
  • BioXcel Therapeutics, Inc. annual Return On Equity for 2022 was -118 %, a 154% decline from 2021.
  • BioXcel Therapeutics, Inc. annual Return On Equity for 2021 was -46.4 %, a 21.8% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 1.87K +1.99K Jan 1, 2023 Dec 31, 2023
2022 -118 -71.6 -154% Jan 1, 2022 Dec 31, 2022
2021 -46.4 +13 +21.8% Jan 1, 2021 Dec 31, 2021
2020 -59.4 +51.6 +46.5% Jan 1, 2020 Dec 31, 2020
2019 -111 -69.7 -169% Jan 1, 2019 Dec 31, 2019
2018 -41.3 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.